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Introduction: Critical Limb Ischaemia (CLI) with tissue loss secondary to lower limb Peripheral Arterial Disease (PAD) 
requires consideration for intervention in the form of endovascular and / or open surgical procedures to achieve 
improved perfusion and limb preservation. An Axillo-Femoral Bypass (AxFB) is only considered in cases where an 
endovascular or abdominal surgical approach to aortoiliac disease is not possible or is deemed too hazardous. Such 
patients may have an unfavourable pattern of arterial disease, significant co-morbidities and / or a hostile abdomen. 
Although prosthetic grafts are typically employed for AxFB procedures, vein grafts are an alternative with a lower risk of 
infection. We present our experience of AxFB grafting using autologous venous conduits in a select group of patients 
with CLI and tissue loss in the context of significant co-morbidities and elevated infection risk. 
 
Methods: A retrospective study of all unilateral AxFB grafts using autologous venous conduits performed at our 
limb salvage unit over a five year period (January 2014-December 2018) was conducted. Data is collected from 
written and electronic medical records as well as radiology, haematology and biochemistry reports. 
 
Results: Seven unilateral AxFB procedures using vein grafts were performed on five patients with CLI and tissue 
loss. Two patients had a second AxFB on the contralateral side on a separate occasion for progressive disease. Four 
patients were male and one was female with an age range of 55–79 years. There were no surgical site infections 
and no perioperative deaths. Graft patency was 86% at one year and 71% at two years. Three out of seven grafts 
(43%) failed during follow up. Two patients with graft occlusion developed CLI and tissue loss, one required 
above knee amputation and the other further bypass surgery. Six patients achieved complete wound healing. One 
patient died from lung cancer. 
 
Conclusion: Our results indicate that AxFB using an autologous venous conduit can be successful in patients with 
CLI and tissue loss in the context of significant co-morbidities and increased risk of infection. Further evidence is 
needed to support our findings and potentially stratify which patients would benefit from a venous, rather than a 
prosthetic, graft. 
 




AF: Atrial Fibrillation; AxFB: Axillo-Femoral Bypass; CIA: 
Common lliac Artery; SFA: Superficial Femoral Artery; PFA: 
Profunda Femoral Artery; IHD: Ischaemic Heart Disease; HTN: 
Hypertension;  PAD:  Peripheral  Arterial  Disease;  DVT:  Deep 
Venous Thrombosis; COPD: Chronic Obstructive Pulmonary 
Disease; MI: Myocardial Infarction; IVDU: Intravenous Drug  
User; CVA: Cerebrovascular Accident; TIA: Transient Ischaemic 
Attack; TASC: Inter-Society Consensus For the Management of 




The incidence and prevalence of Critical Limb Ischaemia (CLI) 
secondary to Peripheral Arterial Disease (PAD) is reported to be 
around 400 cases per million population per year and one in 2500 
respectively [1]. A significant proportion of these patients require 
intervention in the form of an endovascular and / or open surgical 
procedure as a limb saving, and often life saving, measure. 
 
Axillo-Femoral Bypass (AxFB) grafting is reserved for patients in 
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whom first line direct techniques for occlusive aortoiliac disease 
are considered unsuitable. From an anatomical perspective, the 
pattern of arterial disease or the lack of a suitable infrarenal aortic 
segment may preclude direct aortic grafting or endovascular 
intervention. From a clinical perspective, AxFB grafting provides a 
less invasive option for comorbid patients who are in poor 
condition with depleted physiological reserves. In patients with a 
hostile abdomen AxFB grafting is an alternative procedure that 
avoids abdominal exploration and its associated difficulties with 
potential to reduce surgical time and decrease the risk of 
complications, including infection. 
 
The choice of conduit includes a prosthetic graft, commonly 
polyester or polytetrafluoroethylene (PTFE), or an autologous vein. 
The long saphenous and short saphenous veins are favoured [2] but 
the cephalic and basilic veins provide alternatives. In supra-inguinal 
revascularisation, including extra-anatomical bypass grafts such as 
AxFB, a prosthetic graft is generally preferred. The use of prosthetic 
material, however, is associated with an increased risk of infection 
and associated adverse outcomes in the presence of intra-abdominal 
sepsis or peripheral tissue loss with infection [3,4]. An autologous 
vein is the preferred conduit for infra-inguinal bypass [5] but they are 
seldom used for supra-inguinal procedures or extra-anatomical bypass 
grafts such as AxFB [6]. The use of venous conduits for arterial bypass 
is not without complication. Variable calibre, length and quality of 
veins can present challenges. Small calibre veins have a greater risk of 
stenosis [2] while large veins may have pre-existing varicosities which 
necessitate additional procedures at the time of surgery including 
segmental splicing or plication. The presence of areas of weakness 
where a vein has been spliced or repaired may render the venous graft 
more prone to postoperative problems such as graft stenosis, 
aneurysmal dilatation or thrombosis. 
 
In this retrospective review we sought to evaluate patient selection 
and performance of autologous veins as conduits in AxFB grafting at 
our vascular unit. In particular we considered whether the use of 
venous grafts was beneficial in a select group of patients in whom a 
prosthetic AxFB graft was considered more hazardous due to the 
greater risk of infection and its associated complications. 
 
MATERIALS AND METHODS 
 
The limb salvage unit is led by two consultant vascular surgeons 
situated in a district general hospital serving a principally 
Caucasian population of approximately 240,000. All patients who 
had an AxFB procedure using an autologous venous conduit at 
our unit over a five year period (January 2014 to December 2018) 
were identified retrospectively. 
 
Data is collected from written and electronic medical records as 
well as radiology, haematology and biochemistry reports. 
Information collected included patient demographics, co-
morbidities and pre-operative condition, pattern of arterial 
disease, operative details and post-operative complications 
including surgical wound infection, graft occlusion and mortality. 
Particular attention was given to the rationale for use of a venous 
rather than prosthetic conduit in each case. 
 
At our unit all patients presenting with CLI and lower limb tissue loss 
have a Consultant assessment and a baseline US Doppler waveform  
/ Ankle Brachial Pressure Index (ABPI) at the first encounter. This is 
followed by CT or MR angiography if revascularisation is being 
considered. Cases are then discussed at the local Multidisciplinary 
Team (MDT) meeting during which revascularisation approaches 
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are considered. Where appropriate, a plan is then discussed with 
the patient together with clinical assessment of the axillary artery, 
Doppler waveform of upper limb arteries and referral for vascular 
anaesthetic opinion. 
 
After AxFB grafting all patients are entered into a surveillance 
protocol and outreach service, coordinated by the vascular specialist 
nurse, to facilitate close follow up for the patient, their graft and 
wounds. An US duplex scan of the graft is arranged prior to 
discharge and follow up in clinic is initially arranged at two, six and 
twelve weeks. US duplex scans are booked at two monthly intervals 




Seven unilateral AxFB procedures using autologous venous grafts 
were performed on five patients during the study period. Two 
patients had a second AxFB on the contralateral side on separate 
occasions for progressive disease. The grafts were performed as a joint 
procedure by the two consultants at the unit in all cases except one. 
All five patients had been referred to the vascular service with CLI 
and had lower limb tissue loss at presentation. Patient demographics, 
clinical condition and comorbid status is summarised together with 
the classification of their arterial disease using the Rutherford and 
TASC classification systems (Table 1). 
 
The AxFB procedure details are summarised in Table 2. Four right-
sided and three left-sided AxFB procedures were performed. In four 
cases (57%) the long saphenous vein alone was used while two 
 
Table 1: Patient demographics, comorbidities and disease classification 
per procedure.   
Variables  No. (%) or mean ± SD 
Age at operation (years) 66±8 
Gender 
Male M=4 (80) 
Female F=1 (20)  
Smoker 
Former 5 (71) 
Current 2 (29)  
 Hypertension 2 (29) 
 Dyslipidaemia 7 (100) 
Comorbidities Diabetes mellitus 2 (29) 
 Atrial fibrillation 3 (43) 
 End stage renal failure 0 (0) 
Low BMI (<18.5kg/m2) 3 (43) 
Hostile abdomen  1 (14) 
 Haemoglobin g/L 123 ±19.8 
 Low 5 (71) 
 White cell count ×109/L 10.6 ± 2.4 
 Elevated 3 (43) 
Pre-operative CRP mg/L 54±57 
blood results* Mild–Moderately raised (5-50) 3 (43) 
 Significantly raised (>50) 3 (43) 
 Albumin g/L 36 +/- 6.2 
 Low 3 (43) 
 eGFR (ml/min/1.73m2) >90 (100) 
ASA grade 
3 5 (71) 
4 2 (29)  
Rutherford grade III 5 7 (100) 
TASC C 3 (43) 
   
classification D 4 (57) 
 
SD:Standard Deviation *Reference ranges: Haemoglobin 115-165g/L  
(F) &130-180 g/L (M); White Cell Count 4-11 × 109/L; CRP <5mg/L; 
Albumin 35-50 g/L, eGFR >90 ml/min/1.73m2 
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cases (29%) used a combination of upper and lower limb veins 
and one case (14%) used the cephalic vein alone. Common 
Femoral and Profunda Femoris artery (CFA and PFA) 
endarterectomies were performed synchronously in four cases 
(57%) to establish or improve outflow. 
 
Data on peri-operative and early post-operative complications is 
summarised in Table 3. There were no surgical site infections and 
no peri-operative deaths. All grafts were patent at discharge from 
the hospital. One patient required a return to theatre for graft 
thrombectomy two weeks post-operatively to restore graft patency 
and recovered well. 
 
Data on long-term outcomes is summarised in Table 4. The mean 
follow up period was 24 months (range 6-60 months). Three grafts 
(43%) required secondary intervention; all three underwent 
angioplasty +/- stenting for graft stenosis and one graft also 
required open repair of an aneurysmal segment. Graft occlusion 
occurred in three cases and was detected at 4, 8.5 and 19 months. 
Two patients with graft occlusion developed tissue loss during the 
follow up period. Forefoot amputation and adjuvant conservative 
measures were initially successful with improvement in symptoms 
and evidence of wound healing for one of these patients. 
However, following a period of missed appointments, the leg 
deteriorated and the patient required an above knee amputation. 
The other patient had a revascularisation procedure performed at 
another unit during the follow up period. At one year complete 
wound healing had been achieved in six (86%) limbs. The limb 
salvage rate was 100% at one year and 86% at two years despite 
three grafts occluding. The only death during the follow up 
period was due to lung cancer with no deaths related to vascular 
disease or intervention. 
 
The images in Figure 1 were taken at the follow up appointment 
of one patient who had a left AxFB graft followed by a right AxFB 
graft at a later date using an autologous venous conduit in both 
incidences (Figure 1a and 1b). At this review the left foot wound 
had completely healed and the right foot wound showed evidence 
 
Table 2: Procedure details.  
 
Procedure details  No (%) 
    
Procedure 
Left AxFB 3 (43) 
   
Right AxFB 4 (57)  
   
 Long saphenous vein 4 (57) 
    
Conduit 
Cephalic vein 1 (14) 
LSV+CV 1 (14)  
    
 SSV+BV 1 (14) 
    
Adjuvant 
SFA+PFA endarterectomy 4 (57) 
procedure    
 
LSV:Long Saphenous Vein; CV: Cephalic Vein; SSV: Short Saphenous 
Vein; BV: Basilic Vein 
 
Table 3: Early outcomes (<30 days post-operation).  
Variables  No (%) or mean ± SD 
 Bleeding 0 
Complications Surgical site infection 0 
 Graft thrombosis 1 (14) 
Secondary intervention Thrombectomy 1 (14) 
Peri-operative mortality  0 
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Table 4: Long-term outcomes during follow-up period.   
Variables   No (%) or mean ± SD 
Duration of follow up (months) 24 (6-60) 
   Stenosis 3 (43) 
Graft complications 
 Angioplasty ± 3 (43) 
 stenting   
   Aneurysm 1 (14) 
   Open repair 1 (14) 
  2 months 7 (100) 
  4 months 6 (86) 
Graft patency 6 months 6 (86) 
  12 months 5 (71) 
  18 months 5 (71) 
  Total number 3 (43) 
Graft occlusion  Time to detection (months) 10.5 ± 6.3 
during follow up <6 months 1 (14) 
  >6 months 2 (28) 
Wound healing 1 year 6 (86) 
Limb salvage 
 1 year 7 (100) 
 
2 years 6 (86)   
Mortality during follow up 1 (14)* 
 
SD: Standard deviation; *Patient had bilateral AxFB with both grafts 
patent at 5 years and 2.5 years post-operatively during follow up period; 
death due to lung cancer 
 
of healing with healthy granulation tissue at its base (Figure 1c). 
The right foot wound went on to heal completely over the 
following months. Patient consent for these unidentifiable photos 
was not obtained due to the death of the patient and no next of 




Options for revascularisation in occlusive aortoiliac disease have 
expanded with advances in endovascular intervention. When a 
surgical procedure for re-vascularisation of the lower limb is 
indicated in the presence of aortoiliac disease, the preferred 
approach is to explore the aorta and iliac vessels. For those in 
whom this is anatomically unsuitable or too hazardous due to co-
morbidities or a hostile abdomen, an AxFB graft provides a 
simpler and less invasive option [7-10]. Recent studies have 
reported acceptable patency rates [11-13] and limb salvage rates 
[12,14] with a low associated mortality despite significant co-
morbidity and reduced life expectancy in their patient population 
[11,13]. Advances in endovascular intervention have been crucial 
in providing minimally invasive strategies to address graft 
problems such as stenosis thereby maintaining patency [11,15,16]. 
 
AxFB grafting was deemed the optimal revascularisation strategy in 
all seven cases. The patients were in poor clinical condition with 
significant co-morbidities and depleted physiological reserves. The 
ASA grades in all cases were high at 3 and 4 in 71% and 29% 
respectively. In a significant proportion of cases there was a low body 
mass index (BMI) (43%) and /or hypoalbuminaemia (43%); factors 
which are associated with increased risk of post-operative infection 
and poor outcomes [3,17,18]. Anaemia and raised inflammatory 
markers were also prominent in this group. In one patient (14%) the 
presence of a hostile abdomen with multiple abdominal and groin 
scars was a further consideration in favour of AxFB vein grafting, to 
avoid the technical difficulties associated with a direct 
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Figure 1: Images of a patient who underwent left AxFB grafting followed by right AxFB grafting using autologous venous conduits in both instances. 
(1a) Left AxFB graft; (1b) Right AxFB graft and (1c) The left foot wound has completely healed and the right foot wound is healing with healthy 
granulation tissue at its base. 
 
aortoiliac procedure, reducing surgical time and minimising the 
risk of complications, including infection. 
 
All patients included in this study presented acutely with 
deteriorating wounds containing areas of necrosis and / or 
amorphous material that were clinically highly suspicious of 
infection or had microbiology confirmed infection. All patients 
were administered antibiotics on presentation that were 
continued after surgery. 
 
Infection is one of the three major categories used to stage a 
threatened limb in the WIfI (Wound, Ischaemia and Foot Infection) 
classification system [2,19]. In a study of patients undergoing infra-
inguinal bypass for CLI, the presence of foot infection was identified 
as an independent predictor of major amputation [3]. In addition 
post-operative sepsis would be particularly hazardous in this 
population of comorbid patients with poor physiological reserve. 
Although a prosthetic graft is the usual conduit of choice in supra-
inguinal bypass, the use of an autologous venous graft for arterial 
bypass is less likely to be complicated by infection [3,20-23]. Venous 
grafts have been employed to address a variety of challenging clinical 
situations involving infection [20,24-27]. In this study, patients had 
an elevated risk of surgical wound complications including infection. 
Wound healing was potentially compromised 
 
by general frailty, co-morbidity and poor physiological reserve in 
all patients. Surgical site scarring for one patient with a history of 
multiple iliofemoral vascular procedures and another with a 
history of intravenous drug use and multiple groin sinuses was an 
additional consideration for wound complications. In the patients 
with a low BMI there was additional concern that healing and 
immune function were impaired and a prosthetic graft may erode 
through the subcutaneous tissues and become exposed. Further, 
all patients possessed a source of sepsis with clinically suspected or 
proven infection in deteriorating lower limb wounds. 
 
Autologous vein grafts were therefore employed in all cases to 
minimise the risk of surgical wound complications. Despite the 
high risk of infection in our patients there were no cases of 
surgical site wound complications or graft infection in this study 
(Tables 3 and 4). 
 
There was one graft thrombosis at two weeks which required a 
return to theatre for thrombectomy to restore patency after which 
the patient recovered well. Graft stenosis developed in three cases 
(43%) for which successful endovascular intervention was 
performed. Advances in endovascular techniques have provided a 
minimally invasive way to address these problems and maintain 
graft patency [11,15,16]. A graft aneurysm developed in one case  
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following an endovascular procedure (14%) and required an open 
repair. 
 
There were three graft occlusions during the follow up period at 4, 
8.5 and 19 months. One graft occlusion occurred in a patient with 
very complex vascular disease who had a petite stature and a low 
BMI. The diameter of the veins was small at 2-3mm. A prosthetic 
graft had not been chosen as there was a concern that it could erode 
through the scarred subcutaneous tissues leading to exposure and 
infection. One patient did not attend clinic or graft surveillance and 
eventually presented acutely with return of foot tissue loss and an 
occluded graft beyond salvage. The final patient, who had multiple 
procedures on the graft, presented at his routine graft surveillance 
stating that his walking distance had reduced slightly to 150 metres. 
The scan demonstrated an occluded graft. 
 
In this study the wound healing and limb salvage rates were 
encouraging. Within one year, complete wound healing was 
achieved in six (86%) limbs despite two grafts occluding. The limb 
salvage rate was 100% for all seven procedures at one year despite 
two grafts occluding and 86% (6 out of 7) at two years despite 
three grafts occluding. There were no deaths related to vascular 
disease or intervention during follow up. The only death was due 
to lung cancer. 
 
These findings indicate that AxFB grafting with an autologous 
venous conduit can be considered in a select group of patients 
with high operative risk and increased risk of infection where 
major amputation or palliation might have been considered. We 
recognise that the small sample size and retrospective nature of 
this study from a single unit are limitations and that there is no 
comparison with prosthetic graft use for patients with CLI and 
similar co-morbidities. However, there is a paucity of reports on 
the use of autologous venous conduits in AxFB grafting and the 
number of procedures included is very low. This study 
demonstrates that limb salvage is achievable for patients with 
significant co-morbidities presenting with limb and life 
threatening CLI and tissue loss associated with aortoiliac disease 
who are at a high risk of complications that may otherwise have 
faced major amputation or palliative management. Although 
further evidence is needed to establish the role of AxFB grafting 
with an autologous venous conduit for this profile of patients, the 




These findings indicate that unilateral AxFB grafting using 
autologous vein can be employed in a select group of patients 
with CLI and lower limb tissue loss in the context of high 
operative risk and increased risk of infection. In this select group 
of patients, where therapeutic options were limited, this approach 
has been associated with low perioperative complications and 
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